CGEN Compugen Ltd Biological Products, (No Diagnostic Substances) Best Biotech Stocks 2026 →

Compugen (CGEN) Stock: Buy, Sell, or Hold?

$2.02
-0.02 (-0.98%) â–ŧ
5d: -3.35% 30d: +2.54% 90d: -17.21%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (80%)
Quality Score
45/100
Position
FAIR
30-Day Fair Range
$1.95 – $2.10
Position: FAIR
Forward P/E & Valuation
-5.8x
Next 12M consensus est.
Wall Street Target
$4.80
+135.3% upside
Options IV & Volume
7th pct IV
HIGH volume confirmation
Support / Resistance
$1.87 / $2.15
Trend: Downtrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: CGEN is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.

Get Alerted When CGEN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: CGEN is currently trading at $2.02, which is considered fair relative to its 30-day fair value range of $1.95 to $2.10.

Technical Outlook: Technically, CGEN is in a downtrend. Immediate support is located at $1.86, while resistance sits at $2.15.

Market Sentiment: The stock scores a mixed 46/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. In the options market, Implied Volatility is low (7th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.80 (+135.3%). Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Historical Trading Range $1.95 - $2.10
Company Quality Score 45/100 (HOLD)
Options IV Signal 7th percentile (COMPLACENCY WARNING)
Volume Confirmation HIGH
Confidence Score 80.0%

Trading Range & Key Levels

30-Day Trading Range $1.95 - $2.10
Current vs Trading Range FAIR
Expected Move (7 Days) Âą$0.14 (7.1%)
Support Level $1.87
Resistance Level $2.15
Current Trend Downtrend
Technical data as of Nov 17, 2026

Institutional Signals, 13F Whale Activity & Setup Structure

Quantitative Research Feed
Phase & Gamma Walls BREAKDOWN
Days in Phase: 143d (53% conf)
30D Insider Cluster Signal TRACKED
30D Insider Buyers: 0 insiders ($0)
30D Net Insider Flow: $-4,688

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • BULLISH: Options cheap (IV 7th percentile)
  • NEUTRAL: Mixed technical signals (46/100)
  • BULLISH: High volume confirmation
  • BULLISH: Trading 135.3% below Wall St target ($4.80)
  • WARNING: Composite score 45/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -5.83
Wall Street Target $4.80 (+135.3%)
Revenue Growth (YoY) 102.1%
Profit Margin 47.9%
Share CGEN Analysis

Share this live CGEN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (CGEN)

Bullish 2 Retail Mentions
StockTwits Volume
2 msgs
24h retail stream
Last Tracked
Oct 20, 2026
Daily AI digest
AI Retail Discussion Summary: StockTwits messages indicate a strong bullish sentiment towards $CGEN, with buyers taking positions or adding significantly. No recent news articles were found.
Key Retail Themes: buyer interest trend reversal
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 17, 2026 3:38 PM ET
Data refreshes hourly during market hours. Next update: 4:38 PM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Technical Signals Check
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for CGEN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 47 HOLD
ARGX
argenx NV ADR
STRONG BUY
24 analysts
$1147 45 HOLD
SYRE
Spyre Therapeutics Inc.
STRONG BUY
18 analysts
$124 48 HOLD
BNTX
BioNTech SE
BUY
21 analysts
$112 61 BUY
DNTH
Dianthus Therapeutics Inâ€Ļ
STRONG BUY
18 analysts
$139 35 SELL
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals